EPN-V2

FARMA3100 Social Pharmacy and Epidemiology Course description

Course name in Norwegian
Samfunnsfarmasi og epidemiologi
Weight
10.0 ECTS
Year of study
2022/2023
Course history
  • Introduction

    The course covers important groups of pharmaceuticals and natural products, with emphasis on the mechanisms of action. It focuses on the connection between the chemical structure of a pharmaceutical and its pharmacodynamic and pharmacokinetic properties. Emphasis is also placed on the ability of pharmaceuticals to interact with their target molecules, and on the structure-activity relationship (SAR) in physiological environments.

    The table below shows the subjects covered by the course, with credits specified:

    • Medicinal chemistry 8 credits
    • Pharmacognosy 2 credits
  • Required preliminary courses

    After completing the course, the student is expected to have achieved the following learning outcomes defined in terms of knowledge, skills and general competence:

    Knowledge

    The student

    • has knowledge of the chemical and physical properties of pharmaceuticals and of their reactions and reaction mechanisms in a physiological environment
    • is capable of explaining different main groups of pharmaceuticals (ATC classification)
    • is capable of explaining how pharmaceuticals are metabolised in the body
    • is capable of explaining the use of different derivatives of pharmaceutical molecules and their significance in relation to pharmaceutical effects
    • is capable of explaining the main principles of interaction between pharmaceuticals and their target molecules (receptors/enzymes/transport proteins) and how pharmaceuticals influence the activity in the body's different mediator systems
    • is familiar with the classes of natural products and their traditional use

    Skills

    The student is capable of

    • assessing the structure-activity relationship and molecular mechanisms of action for the main groups of pharmaceuticals and natural products
    • analysing the chemical and physical properties of the substances, functional groups, stereochemistry, absorption and metabolism, structure-activity relationship (SAR), the connection between the chemical structure of pharmaceuticals and their pharmacodynamic properties

    General competence

    The student is capable of

    • independently acquiring knowledge about and assessing the properties of a pharmaceutical product and its activity relationship
  • Learning outcomes

    After completing the course, the student is expected to have achieved the following learning outcomes defined in terms of knowledge, skills and general competence:

    Knowledge

    The student

    • has broad knowledge of the role of pharmaceuticals in the prevention and treatment of illness from an individual and societal perspective
    • has broad knowledge of pharmaceutical services
    • is familiar with the routines and procedures for medication reviews and discussions
    • is familiar with the pharmaceuticals users' need of information in different life situations and with different illnesses;
    • is capable of explaining key concepts in the field of epidemiological methodology
    • is capable of explaining ethical dilemmas relevant to epidemiological research
    • is familiar with key statistical concepts used in medical statistics

    Skills

    The student is capable of

    • carrying out source searches and providing information to pharmaceuticals users in different life situations and with different illnesses, and with varying information needs
    • applying epidemiological concepts
    • applying digital tools in statistical calculations and graphical presentations of prescription statistics and other figures that concern the use of pharmaceuticals
    • using evidence-based subject matter and innovation in project work, communicating this and contributing to discussions in the field

    General competence

    The student

    • has insight into pharmaceutical issues in society
    • is capable of reflecting on the correct use of pharmaceuticals in special groups of patients
    • is capable of reflecting on the quality and validity of information provided by different sources
    • is capable of contributing to making innovation and entrepreneurship a way of thinking in healthcare
  • Teaching and learning methods

    Exam content: The learning outcomes

    Exam form: Supervised individual written exam, 4 hours

  • Course requirements

    Molecular model set

  • Assessment

    Grade scale A-F

  • Permitted exam materials and equipment

    One external and one internal examiner will assess all the papers

  • Grading scale

    Grade scale A-F

  • Examiners

    Oral exam: One external and one internal examiner will assess all the candidates.

    Portfolio exam: One external and one internal examiner will assess at least 30 % of the assigments. Two internal examiners will assess the remaining assignments. The external examiner¿s assessment shall benefit all the students.